Rossari Biotech Q2 FY26 consolidated PAT increases to Rs. 36.87 Cr
General

Rossari Biotech Q2 FY26 consolidated PAT increases to Rs. 36.87 Cr

Rossari Biotech has posted net profit of Rs. 70.47 crores for the 6 months period ended September 30, 2025

  • By ICN Bureau | October 16, 2025

Rossari Biotech Limited has reported consolidated financial results for the period ended September 30, 2025.

Rossari Biotech has posted net profit of Rs. 36.87 crore for the period ended September 30, 2025 as against net profit of Rs. 33.59 crores for the period ended June 30, 2025. The company posted net profit of Rs.35.33 crore for the period ended September 30, 2024.

Rossari Biotech has reported total income of Rs. 587.71 crore during the period ended September 30, 2025 as compared to Rs. 544.91 crore during the period ended June 30, 2025. The company reported total income of Rs. 499.07 crores during the period ended September 30, 2024.

For the half year ended September 30, 2025, Rossari Biotech has reported total income of Rs. 113.26 crore as compared to Rs. 989.66 crores during the 6 Months period ended September 30, 2024.

Rossari Biotech has posted net profit of Rs. 70.47 crores for the 6 months period ended September 30, 2025 as against net profit of Rs.70.23 crores for the 6 months period ended September 30, 2024.

Other Related stories

Startups

Chemical

Petrochemical

Energy

Digitization